Followers | 1318 |
Posts | 26925 |
Boards Moderated | 6 |
Alias Born | 12/10/2012 |
Friday, September 03, 2021 11:02:52 AM
Coming in here
Looks good so far today
GO $IPHA
Recent IPHA News
- Innate Pharma co-organise un symposium scientifique en présence d’experts de l’Immunotherapie à New York le 3 octobre 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024 • Business Wire • 09/30/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 10:03:48 AM
- Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors • Business Wire • 09/23/2024 05:00:00 AM
- Innate Pharma reçoit l’autorisation de l’agence américaine du médicament d’initier le développement clinique d’IPH4502, son ADC ciblant Nectine-4, dans les tumeurs solides • Business Wire • 09/23/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:15:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 10:07:46 AM
- U.S. Index Futures Climb Ahead of Key Economic Data Releases; Oil Prices Rise • IH Market News • 09/12/2024 10:04:12 AM
- Innate Pharma Reports First Half 2024 Business Update and Financial Results • Business Wire • 09/12/2024 05:00:00 AM
- Innate Pharma présente l’avancée de son portefeuille et ses résultats financiers au premier semestre 2024 • Business Wire • 09/12/2024 05:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/11/2024 08:00:52 PM
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Innate Pharma SA: Présentation de données de monalizumab issues de l’étude de Phase 2 NeoCOAST-2 dans le cancer du poumon non à petites cellules au stade précoce à la conférence mondiale sur le cancer du poumon 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2024 • Business Wire • 09/05/2024 05:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update • Business Wire • 09/05/2024 05:00:00 AM
- Innate Pharma annonce sa participation à la 26ème Annual Global Investment Conference de H.C. Wainwright • Business Wire • 09/04/2024 05:00:00 AM
- Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/04/2024 05:00:00 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conference • Business Wire • 08/01/2024 05:00:00 AM
- INNATE PHARMA ANNONCE SA PARTICIPATION A UNE PROCHAINE CONFERENCE INVESTISSEURS • Business Wire • 08/01/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juillet 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juin 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang • Business Wire • 06/17/2024 05:00:00 AM
- Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial • Business Wire • 06/17/2024 05:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM